Department of Neurology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
CNS Neurosci Ther. 2023 Jul;29(7):1898-1906. doi: 10.1111/cns.14148. Epub 2023 Mar 8.
Whether the coronavirus disease-2019 (COVID-19) pandemic is associated with a long-term negative impact on acute stroke care remains uncertain. This study aims to compare the timing of key aspects of stroke codes between patients before and after the COVID-19 pandemic.
This retrospective cohort study was conducted at an academic hospital in Shanghai, China and included all adult patients with acute ischemic stroke hospitalized via the emergency department (ED) stroke pathway during the 24 months since the COVID-19 outbreak (COVID-19: January 1, 2020-December 31, 2021). The comparison cohort included patients with ED stroke pathway visits and hospitalizations during the same period (pre-COVID-19: January 1, 2018-December 31, 2019). We compared critical time points of prehospital and intrahospital acute stroke care between patients during the COVID-19 era and patients during the pre-COVID-19 era using t test, χ , and Mann-Whitney U test where appropriate.
A total of 1194 acute ischemic stroke cases were enrolled, including 606 patients in COVID-19 and 588 patients in pre-COVID-19. During the COVID-19 pandemic, the median onset-to-hospital time was about 108 min longer compared with the same period of pre-COVID-19 (300 vs 192 min, p = 0.01). Accordingly, the median onset-to-needle time was 169 min in COVID-19 and 113 min in pre-COVID-19 (p = 0.0001), and the proportion of patients with onset-to-hospital time within 4.5 h was lower (292/606 [48.2%] vs 328/558 [58.8%], p = 0.0003) during the pandemic period. Furthermore, the median door-to-inpatient admission and door-to-inpatient rehabilitation times increased from 28 to 37 h and from 3 to 4 days (p = 0.014 and 0.0001).
During the 24 months of COVID-19, a prolongation of stroke onset to hospital arrival and to intravenous rt-PA administration times were noted. Meanwhile, acute stroke patients needed to stay in the ED for a longer time before hospitalization. Educational system support and process optimization should be pursued in order to acquire timely delivery of stroke care during the pandemic.
新型冠状病毒病 2019(COVID-19)大流行是否对急性脑卒中治疗产生长期负面影响仍不确定。本研究旨在比较 COVID-19 大流行前后患者的脑卒中编码关键时间。
本回顾性队列研究在上海的一家学术医院进行,纳入了通过急诊(ED)脑卒中途径住院的所有成年急性缺血性脑卒中患者,时间为 COVID-19 爆发后 24 个月(COVID-19:2020 年 1 月 1 日-2021 年 12 月 31 日)。对照组纳入了同一时期(COVID-19 前:2018 年 1 月 1 日-2019 年 12 月 31 日)ED 脑卒中途径就诊和住院的患者。我们使用 t 检验、χ 2 检验和 Mann-Whitney U 检验比较了 COVID-19 时期和 COVID-19 前时期患者的院前和院内急性脑卒中治疗的关键时间点。
共纳入 1194 例急性缺血性脑卒中患者,其中 COVID-19 组 606 例,COVID-19 前组 588 例。在 COVID-19 大流行期间,与 COVID-19 前同期相比,发病至入院时间中位数延长约 108 分钟(300 分钟比 192 分钟,p=0.01)。相应地,发病至静脉溶栓时间中位数在 COVID-19 组为 169 分钟,在 COVID-19 前组为 113 分钟(p=0.0001),发病至入院时间在 4.5 小时内的患者比例较低(292/606 [48.2%]比 328/558 [58.8%],p=0.0003)。此外,门到住院和门到康复的时间中位数从 28 小时增加到 37 小时,从 3 天增加到 4 天(p=0.014 和 0.0001)。
在 COVID-19 的 24 个月期间,脑卒中发病至入院和静脉溶栓治疗时间延长。同时,急性脑卒中患者在入院前需要在 ED 停留更长时间。为了在大流行期间获得及时的脑卒中治疗,应寻求教育系统的支持和流程优化。